FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Macleods Pharma Rizatriptan Benzoate Orally Disintegrating Recall

Rizatriptan Benzoate Orally Disintegrating Tablets 5mg, 12 Tablets (2 x 6 Unit-Dose Tab…

MACLEODS PHARMA USA, INC · Princeton, NJ

Risk level
Class III
Reported by FDA
Nov 3, 2021
Recall ID
D-0079-2022
Check your lot numberHow we source this data

Summary

Macleods Pharma recalled Rizatriptan Benzoate Orally Disintegrating starting Oct 18, 2021. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0079-2022 on Nov 3, 2021. Reason: Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples. Status: Terminated.

Why it was recalled

Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.

Product description

Rizatriptan Benzoate Orally Disintegrating Tablets 5mg, 12 Tablets (2 x 6 Unit-Dose Tablets) Blister Packs, Rx only, Manufactured for: Macleods Pharma USA Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA, NDC 33342-093-41

Lot numbers, UPCs & expiration codes

Lot #: BRL2102A, BRL2103A, exp. date 04/2025

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0079-2022
Classification
Class III
Status
Terminated
Recall initiated
Oct 18, 2021
FDA report date
Nov 3, 2021
Quantity
13,260 Blister Packs/238,680 tablets
Recall type
Voluntary: Firm initiated
Recalling firm
MACLEODS PHARMA USA, INC

Original FDA data

Every field from FDA enforcement report D-0079-2022, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
88872
Address
103 College Rd E Fl 2
Code information
Lot #: BRL2102A, BRL2103A, exp. date 04/2025
Postal code
08540-6611
Report date
Nov 3, 2021
Product type
Drugs
Recall number
D-0079-2022
Classification
Class III
Recalling firm
MACLEODS PHARMA USA, INC
Product quantity
13,260 Blister Packs/238,680 tablets
Termination date
Apr 24, 2024
Reason for recall
Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Rizatriptan Benzoate Orally Disintegrating Tablets 5mg, 12 Tablets (2 x 6 Unit-Dose Tablets) Blister Packs, Rx only, Manufactured for: Macleods Pharma USA Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA, NDC 33342-093-41
Distribution pattern
Nationwide within the United States
Recall initiation date
Oct 18, 2021
Initial firm notification
Letter
Center classification date
Oct 28, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0079-2022, published Nov 3, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls